Literature DB >> 19002597

The analysis of metastasis in transgenic mouse models.

Yves Hüsemann1, Christoph A Klein.   

Abstract

Human metastasis has been modeled mostly by xenotransplantation of cell lines in immunodeficient mice. Since this approach frequently uses cell lines derived from metastases, it ignores the significant role of cellular selection processes before and during metastatic progression and, in fact, models metastasis from metastasis and not metastasis from primary tumours. While the importance of the latter for the fate of patients is proven, the existence and clinical relevance of metastasis from metastasis is still unsettled. On the other hand, transgenic or gene knockout models of cancer offer novel experimental approaches to dissect the metastatic cascade from its very beginnings. Here, we briefly review the attempts to model metastatic progression and the strengths and limitations of the different experimental approaches and describe how transgenic mouse models recently helped to promote our understanding of systemic cancer progression.

Entities:  

Mesh:

Year:  2008        PMID: 19002597     DOI: 10.1007/s11248-008-9225-0

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  23 in total

Review 1.  Endometriosis.

Authors:  Linda C Giudice; Lee C Kao
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

2.  Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.

Authors:  G Schlimok; I Funke; B Holzmann; G Göttlinger; G Schmidt; H Häuser; S Swierkot; H H Warnecke; B Schneider; H Koprowski; G Riethmüller
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  A multigenic program mediating breast cancer metastasis to bone.

Authors:  Yibin Kang; Peter M Siegel; Weiping Shu; Maria Drobnjak; Sanna M Kakonen; Carlos Cordón-Cardo; Theresa A Guise; Joan Massagué
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

4.  Systemic spread is an early step in breast cancer.

Authors:  Yves Hüsemann; Jochen B Geigl; Falk Schubert; Piero Musiani; Manfred Meyer; Elke Burghart; Guido Forni; Roland Eils; Tanja Fehm; Gert Riethmüller; Christoph A Klein
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

5.  Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts.

Authors:  D Tarin; J E Price; M G Kettlewell; R G Souter; A C Vass; B Crossley
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

6.  Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes.

Authors:  Tan A Ince; Andrea L Richardson; George W Bell; Maki Saitoh; Samuel Godar; Antoine E Karnoub; James D Iglehart; Robert A Weinberg
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

7.  Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

Authors:  Jing Yang; Sendurai A Mani; Joana Liu Donaher; Sridhar Ramaswamy; Raphael A Itzykson; Christophe Come; Pierre Savagner; Inna Gitelman; Andrea Richardson; Robert A Weinberg
Journal:  Cell       Date:  2004-06-25       Impact factor: 41.582

8.  Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression.

Authors:  T Lifsted; T Le Voyer; M Williams; W Muller; A Klein-Szanto; K H Buetow; K W Hunter
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

Review 9.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

10.  From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression.

Authors:  Oleg Schmidt-Kittler; Thomas Ragg; Angela Daskalakis; Martin Granzow; Andre Ahr; Thomas J F Blankenstein; Manfred Kaufmann; Joachim Diebold; Hans Arnholdt; Peter Muller; Joachim Bischoff; Detlev Harich; Gunter Schlimok; Gert Riethmuller; Roland Eils; Christoph A Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

View more
  8 in total

1.  Feline bone marrow-derived mesenchymal stromal cells (MSCs) show similar phenotype and functions with regards to neuronal differentiation as human MSCs.

Authors:  Jessian L Munoz; Steven J Greco; Shyam A Patel; Lauren S Sherman; Suresh Bhatt; Rekha S Bhatt; Jeffrey A Shrensel; Yan-Zhong Guan; Guiqin Xie; Jiang-Hong Ye; Pranela Rameshwar; Allan Siegel
Journal:  Differentiation       Date:  2012-07-21       Impact factor: 3.880

Review 2.  Genetically engineered mouse models in cancer research.

Authors:  Jessica C Walrath; Jessica J Hawes; Terry Van Dyke; Karlyne M Reilly
Journal:  Adv Cancer Res       Date:  2010       Impact factor: 6.242

Review 3.  In vivo animal models for studying brain metastasis: value and limitations.

Authors:  Inderjit Daphu; Terje Sundstrøm; Sindre Horn; Peter C Huszthy; Simone P Niclou; Per Ø Sakariassen; Heike Immervoll; Hrvoje Miletic; Rolf Bjerkvig; Frits Thorsen
Journal:  Clin Exp Metastasis       Date:  2013-01-16       Impact factor: 5.150

4.  A simple selection-free method for detecting disseminated tumor cells (DTCs) in murine bone marrow.

Authors:  Kenneth C Valkenburg; Sarah R Amend; James E Verdone; Emma E van der Toom; James R Hernandez; Michael A Gorin; Kenneth J Pienta
Journal:  Oncotarget       Date:  2016-10-25

5.  Cathepsin B Is Upregulated and Mediates ECM Degradation in Colon Adenocarcinoma HT29 Cells Overexpressing Snail.

Authors:  Jakub Kryczka; Izabela Papiewska-Pajak; M Anna Kowalska; Joanna Boncela
Journal:  Cells       Date:  2019-02-27       Impact factor: 6.600

Review 6.  Detecting Tumor Metastases: The Road to Therapy Starts Here.

Authors:  M E Menezes; S K Das; I Minn; L Emdad; X-Y Wang; D Sarkar; M G Pomper; P B Fisher
Journal:  Adv Cancer Res       Date:  2016-08-17       Impact factor: 6.242

7.  TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling.

Authors:  Paloma Bragado; Yeriel Estrada; Falguni Parikh; Sarah Krause; Carla Capobianco; Hernan G Farina; Denis M Schewe; Julio A Aguirre-Ghiso
Journal:  Nat Cell Biol       Date:  2013-10-27       Impact factor: 28.824

Review 8.  Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells.

Authors:  A Tachtsidis; L M McInnes; N Jacobsen; E W Thompson; C M Saunders
Journal:  Clin Exp Metastasis       Date:  2016-05-17       Impact factor: 5.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.